Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor Drug Class List
✉ Email this page to a colleague
Drugs in Drug Class: Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Amneal | ACYCLOVIR | acyclovir | CREAM;TOPICAL | 208766-001 | Nov 9, 2020 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
| Rubicon | ACYCLOVIR | acyclovir | SUSPENSION;ORAL | 215724-001 | Aug 18, 2022 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
| Zydus Lifesciences | ACYCLOVIR | acyclovir | OINTMENT;TOPICAL | 205974-001 | Mar 15, 2019 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
| Padagis Israel | ACYCLOVIR | acyclovir | CREAM;TOPICAL | 208702-001 | Feb 4, 2019 | AB | RX | No | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
| Carlsbad Technology | ACYCLOVIR | acyclovir | CAPSULE;ORAL | 206261-001 | Aug 16, 2017 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
| Glenmark Pharms Sa | ACYCLOVIR | acyclovir | OINTMENT;TOPICAL | 205510-001 | Jul 31, 2017 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
| Square Pharms | ACYCLOVIR | acyclovir | TABLET;ORAL | 209366-001 | Oct 7, 2019 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
